Zimmer Biomet receives FDA clearance for ROSA Shoulder System
Evidence notes
- Zimmer Biomet received U.S. FDA clearance for the ROSA Shoulder System.
- The company described ROSA Shoulder as the first robotic assistant for shoulder replacement surgery.
- The clearance expands Zimmer Biomet's ROSA robotics portfolio from knee and hip into shoulder arthroplasty.
Company context
Zimmer Biomet develops orthopedic products and ROSA robotic systems for knee, hip, shoulder and neurosurgical workflows.